Correction (Article Updated in Database)

May 7, 1998

An article in the May 5, 1998 issue of BioWorld Today should have identified the CEO of NitroMed as Michael Loberg.

Today's news in brief

BioWorld

BioWorld briefs for May 27, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 26, 2026

Microscopy of a cross-section of mouse skin containing melanoma tumors

Researchers identify innate immune barrier against melanoma

BioWorld

Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...

In the clinic for May 26, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...

Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers

BioWorld Science

Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...

Correction (Article Updated in Database)

Related Articles